Virogin Biotech
Vancouver
About Virogin Biotech
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $204.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Sep 2021)
- Website: virogin.com
- Phone: +86 (755) 33122597
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/virogin-biotech-41527 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.